WallStSmart

Ping An Biomedical Co., Ltd. (PASW)vsPDD Holdings Inc. (PDD)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

PDD Holdings Inc. generates 1295449% more annual revenue ($442.40B vs $34.15M). PDD leads profitability with a 21.6% profit margin vs -37.6%. PDD earns a higher WallStSmart Score of 76/100 (B+).

PASW

Avoid

23

out of 100

Grade: F

Growth: 2.7Profit: 2.0Value: 5.0Quality: 5.5
Piotroski: 3/9

PDD

Strong Buy

76

out of 100

Grade: B+

Growth: 6.0Profit: 8.0Value: 9.3Quality: 8.0
Piotroski: 2/9Altman Z: 3.69
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for PASW.

PDDUndervalued (+70.6%)

Margin of Safety

+70.6%

Fair Value

$363.48

Current Price

$85.07

$278.41 discount

UndervaluedFair: $363.48Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

PASW1 strengths · Avg: 10.0/10
Price/BookValuation
0.6x10/10

Reasonable price relative to book value

PDD6 strengths · Avg: 9.7/10
P/E RatioValuation
8.6x10/10

Attractively priced relative to earnings

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Free Cash FlowQuality
$24.12B10/10

Generating 24.1B in free cash flow

Altman Z-ScoreHealth
3.6910/10

Safe zone — low bankruptcy risk

Market CapQuality
$116.09B9/10

Large-cap with strong market position

Return on EquityProfitability
22.9%9/10

Every $100 of equity generates 23 in profit

Areas to Watch

PASW4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$23.49M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-67.4%2/10

ROE of -67.4% — below average capital efficiency

PDD2 concerns · Avg: 2.5/10
Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

EPS GrowthGrowth
-14.9%2/10

Earnings declined 14.9%

Comparative Analysis Report

WallStSmart Research

Bull Case : PASW

The strongest argument for PASW centers on Price/Book.

Bull Case : PDD

The strongest argument for PDD centers on P/E Ratio, Debt/Equity, Free Cash Flow. Profitability is solid with margins at 21.6% and operating margin at 18.4%. Revenue growth of 11.0% demonstrates continued momentum.

Bear Case : PASW

The primary concerns for PASW are EPS Growth, Market Cap, Piotroski F-Score.

Bear Case : PDD

The primary concerns for PDD are Piotroski F-Score, EPS Growth.

Key Dynamics to Monitor

PASW profiles as a turnaround stock while PDD is a mature play — different risk/reward profiles.

PDD is growing revenue faster at 11.0% — sustainability is the question.

PDD generates stronger free cash flow (24.1B), providing more financial flexibility.

Monitor TEXTILE MANUFACTURING industry trends, competitive dynamics, and regulatory changes.

Bottom Line

PDD scores higher overall (76/100 vs 23/100), backed by strong 21.6% margins and 11.0% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Ping An Biomedical Co., Ltd.

CONSUMER CYCLICAL · TEXTILE MANUFACTURING · USA

Ping An Biomedical Co., Ltd., provides supply chain management services in the apparel industry in China.

PDD Holdings Inc.

CONSUMER CYCLICAL · INTERNET RETAIL · China

Pinduoduo Inc., operates an electronic commerce platform in the People's Republic of China. The company is headquartered in Shanghai, the People's Republic of China.

Visit Website →

Want to dig deeper into these stocks?